Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma by Edeline, Julien, MD, Mottier, Stéphanie, BSc, Vigneau, Cécile, MD, PhD, Jouan, Florence, Perrin, Christophe, MD, Zerrouki, Selim, MD, Fergelot, Patricia, MD, Patard, Jean-Jacques, MD, PhD, Rioux-Leclercq, Nathalie, MD, PhD

Get full text

Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival by Dagher, Julien, MBBS, Dugay, Frédéric, PharmD, Rioux-Leclercq, Nathalie, MD, PhD, Verhoest, Gregory, MD, Oger, Emmanuel, MD, PhD, Bensalah, Karim, MD, PhD, Cabillic, Florian, PharmD, PhD, Jouan, Florence, MILT, Kammerer-Jacquet, Solene-Florence, MD, Fergelot, Patricia, MD, PhD, Vigneau, Cécile, MD, PhD, Arlot-Bonnemains, Yannick, PhD, Belaud-Rotureau, Marc-Antoine, PharmD, PhD

Get full text

Plasma level and tissue expression of vascular endothelial growth factor in renal cell carcinoma: a prospective study of 50 cases by Rioux-Leclercq, Nathalie, MD, PhD, Fergelot, Patricia, MD, PhD, Zerrouki, Salim, MD, Leray, Emmanuelle, MD, Jouan, Florence, Bellaud, Pascale, Epstein, Jonathan I., MD, Patard, Jean-Jacques, MD

Get full text